MENU
AMPH
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Amphastar Pharmaceuticals (AMPH) Earnings Date & Reports

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products... Show more

A.I. Advisor
published Earnings

AMPH is expected to report earnings to fall 5.04% to 86 cents per share on November 09

Amphastar Pharmaceuticals AMPH Stock Earnings Reports
Q3'26
Est.
$0.86
Q2'26
Beat
by $0.28
Q1'26
Missed
by $0.30
Q4'25
Missed
by $0.20
Q3'25
Beat
by $0.10
The last earnings report on August 06 showed earnings per share of 91 cents, beating the estimate of 62 cents. With 147.68K shares outstanding, the current market capitalization sits at 1.17B.
View a ticker or compare two or three
AMPH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of proprietary injectable and inhalation products

Industry PharmaceuticalsGeneric

Industry
Pharmaceuticals Other
Address
11570 6th Street
Phone
+1 909 980-9484
Employees
1976
Web
https://www.amphastar.com